Retinitis Pigmentosa (RP) is a hereditary retinopathy that affects about 2.5 million people
worldwide. It is characterized with progressive loss of rods and cones and causes severe …

Age-related macular degeneration (AMD), a progressive condition that is untreatable in up
to 90% of patients, is a leading cause of blindness in the elderly worldwide. The two forms of …

Soft bioelectronic devices provide new opportunities for next-generation implantable
devices owing to their soft mechanical nature that leads to minimal tissue damages and …

Abstract The Argus® II Retinal Prosthesis System (Second Sight Medical Products) is the
first prosthetic vision device to obtain regulatory approval in both Europe and the USA. As …

A subretinal visual implant (Alpha IMS, Retina Implant AG, Reutlingen, Germany) was
implanted in 29 blind participants with outer retinal degeneration in an international …

Assistive technology for the visually impaired and blind people is a research field that is
gaining increasing prominence owing to an explosion of new interest in it from disparate …

The diverse vision systems found in nature can provide interesting design inspiration for
imaging devices, ranging from optical subcomponents to digital cameras and visual …

Retinal prostheses are designed to restore a basic sense of sight to people with profound
vision loss. They require a relatively intact posterior visual pathway (optic nerve, lateral …

Retinal transplantation therapy for retinitis pigmentosa is increasingly of interest due to
accumulating evidence of transplantation efficacy from animal studies and development of …

Patients with retinal degeneration lose sight due to the gradual demise of photoreceptors.
Electrical stimulation of surviving retinal neurons provides an alternative route for the …